NDC Package 55111-258-60 Ziprasidone Hydrochloride

Capsule Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55111-258-60
Package Description:
60 CAPSULE in 1 BOTTLE
Product Code:
Proprietary Name:
Ziprasidone Hydrochloride
Non-Proprietary Name:
Ziprasidone Hydrochloride
Substance Name:
Ziprasidone Hydrochloride
Usage Information:
Ziprasidone hydrochloride capsules are indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone’s greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [see Warnings and Precautions (5.3)]. Prolongation of the QTc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. In many cases this would lead to the conclusion that other drugs should be tried first. Whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see Warnings and Precautions (5.3)]Schizophrenia Ziprasidone hydrochloride capsules are indicated for the treatment of schizophrenia in adults [see Clinical Studies (14.1)]Bipolar I Disorder (Acute Mixed or Manic Episodes and Maintenance Treatment as an Adjunct to Lithium or Valproate) Ziprasidone hydrochloride capsules are indicated as monotherapy for the acute treatment of adults with manic or mixed episodes associated with bipolar I disorder [see Clinical Studies (14.2)]. Ziprasidone hydrochloride capsules are indicated as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder in adults [see Clinical Studies (14.2)].
11-Digit NDC Billing Format:
55111025860
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
60 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 313776 - ziprasidone HCl 40 MG Oral Capsule
  • RxCUI: 313776 - ziprasidone 40 MG Oral Capsule
  • RxCUI: 313776 - ziprasidone (as ziprasidone hydrochloride monohydrate) 40 MG Oral Capsule
  • RxCUI: 313777 - ziprasidone HCl 60 MG Oral Capsule
  • RxCUI: 313777 - ziprasidone 60 MG Oral Capsule
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Dr. Reddy's Laboratories Limited
    Dosage Form:
    Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA077565
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-02-2012
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    55111-258-01100 CAPSULE in 1 BOTTLE
    55111-258-05500 CAPSULE in 1 BOTTLE
    55111-258-3030 CAPSULE in 1 BOTTLE
    55111-258-7810 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK
    55111-258-813 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK
    55111-258-9090 CAPSULE in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55111-258-60?

    The NDC Packaged Code 55111-258-60 is assigned to a package of 60 capsule in 1 bottle of Ziprasidone Hydrochloride, a human prescription drug labeled by Dr. Reddy's Laboratories Limited. The product's dosage form is capsule and is administered via oral form.

    Is NDC 55111-258 included in the NDC Directory?

    Yes, Ziprasidone Hydrochloride with product code 55111-258 is active and included in the NDC Directory. The product was first marketed by Dr. Reddy's Laboratories Limited on March 02, 2012 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 55111-258-60?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 60.

    What is the 11-digit format for NDC 55111-258-60?

    The 11-digit format is 55111025860. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-255111-258-605-4-255111-0258-60